Direct lysis buffer and the detection of hiv-1 plasma viremia

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/70 (2006.01) C12N 1/06 (2006.01) C12N 7/00 (2006.01) C12N 9/50 (2006.01) C12N 15/10 (2006.01) C12Q 1/68 (2006.01) C12S 3/02 (2006.01)

Patent

CA 2161337

Immunocapture of plasma HIV-1, coupled with direct lysis of the virions and a simplified method of reverse transcription and amplification of the HIV-1 cDNA by the Polymerase Chain Reaction (PCR) represents a rapid and highly sensitive method to monitor HIV- I disease progression. This method is also less time and labor intensive than quantitative culture. In addition, the development of a method to directly lyse the immunocaptured virions and a simplified single step reverse transcription (RT)/PCR procedure eliminated the need for organic solvent extraction and reduced the number of steps in the procedure. A direct lysis buffer was formulated to isolate plasma HIV-1 RNA for direct use in the RT and PCR reactions, thus eliminating the need for organic solvent extraction and ethanol precipitation. This resulted in a significant saving of time needed to complete the assay and significantly reduces the possibility of contamination associated with PCR reactions. The immunocapture-RT/PCR assay was used to show that vertical transmission of HIV-1 from a mother to her child depended largely on factors other that viral load. Conversely, the plasma viral load played a significant role in transfusion associated transmission of HIV-1 infection. Finally, the detection and quantitation of plasma associated viral load by immunocapture-RT/PCR may provide an additional marker of disease progression and may aid in determining the efficacy of various HIV therapeutics.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Direct lysis buffer and the detection of hiv-1 plasma viremia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Direct lysis buffer and the detection of hiv-1 plasma viremia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Direct lysis buffer and the detection of hiv-1 plasma viremia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1492896

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.